{"product_id":"veev-pestle-analysis","title":"(VEEV) Veeva Systems Inc. PESTLE Analysis Research","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-List-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Competitive Advantage Starts with This Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThis Veeva Systems Inc. PESTLE Analysis explains the political, economic, social, technological, legal, and environmental forces shaping Veeva’s strategy and risks; the page includes a real preview\/sample so you can judge style and depth, and purchasing the full report delivers the complete ready-to-use company-specific analysis for presentations, strategy, or investment decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003ePolitical factors\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e6-region public policy exposure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVeeva Systems Inc. sells in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America, so it faces different healthcare procurement rules, data-residency laws, and cloud policy views in each market. Public-sector digital-health programs can speed or slow life sciences software adoption, especially where regulators favor local hosting or tighter vendor review. That split policy backdrop matters because Veeva’s global customer base spans regulated markets and government-linked buying cycles.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCross-border health data controls\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLife sciences clients move clinical and commercial data across borders, so Veeva Systems Inc. must meet country rules on hosting, residency, and transfer. The EU GDPR can fine firms up to 4% of global annual turnover, which makes cross-border controls a contract issue, not just IT. Political shifts in privacy, sovereignty, or cyber policy can force new deployment designs and raise compliance costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare digitization support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGovernments keep pushing electronic records, eClinical systems, and digital compliance, and that lifts demand for Veeva Systems Inc. Vault and commercial cloud tools that replace paper-heavy workflows. In FY2025, Veeva Systems Inc. reported revenue of about $2.75 billion, showing how policy-led digitization supports adoption across pharma and biotech. As incentives for digital healthcare spread, more customers move faster into cloud-based compliance and trial systems.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eTrade and sanctions risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVeeva serves global pharma clients, so export controls and sanctions can block sales, support, and partner tools in specific countries. In FY2025, Veeva’s revenue was about $2.75 billion, so even small market limits can hit a large base. Geopolitical friction also raises travel, compliance, and delivery costs for cross-border work.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eGlobal pharma faces sanctions exposure.\u003c\/li\u003e\n\u003cli\u003eMarket bans can cut support access.\u003c\/li\u003e\n\u003cli\u003eCross-border costs stay higher.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003ePublic funding for life sciences\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePublic funding for life sciences stays a key driver for Veeva Systems Inc. In the U.S., NIH funding is about $48 billion in FY2025, and that money feeds more trials, filings, and regulated workflows that Veeva software can support.\u003c\/p\u003e\n\u003cp\u003eWhen grant budgets rise, drug pipelines usually widen, so demand for clinical, regulatory, and quality tools grows with it.\u003c\/p\u003e\n\u003cp\u003eIf funding tightens, trial starts and new system buys can slow, which can delay Veeva Systems Inc. revenue tied to new deployments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFY2025 NIH funding: about $48 billion\u003c\/li\u003e\n\u003cli\u003eMore grants mean more trials and submissions\u003c\/li\u003e\n\u003cli\u003eLower budgets can slow pipeline activity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVeeva’s Growth Hinges on Health Data Policy Shifts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical risk for Veeva Systems Inc. is mostly about shifting health-data, cloud, and cross-border rules. FY2025 revenue was about $2.75 billion, so even small policy changes in Europe, the US, or Asia can affect rollout speed, compliance cost, and contract terms. Public funding also matters: NIH FY2025 funding was about $48 billion, which supports trials and regulated workflows that drive demand.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePolitical factor\u003c\/th\u003e\n\u003cth\u003eFY2025 \/ latest data\u003c\/th\u003e\n\u003cth\u003eWhy it matters\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eVeeva Systems Inc. revenue\u003c\/td\u003e\n\u003ctd\u003e$2.75 billion\u003c\/td\u003e\n\u003ctd\u003ePolicy shifts can move a large base\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNIH funding\u003c\/td\u003e\n\u003ctd\u003e$48 billion\u003c\/td\u003e\n\u003ctd\u003eSupports trials and submissions\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCross-border rules\u003c\/td\u003e\n\u003ctd\u003eGDPR up to 4% of turnover\u003c\/td\u003e\n\u003ctd\u003eRaises compliance and hosting cost\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"product-includes\"\u003e\n\u003cdiv class=\"product-includes__container\"\u003e\n\u003ch2 id=\"product-includes-title\" class=\"product-includes__title\"\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-includes__grid\"\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Detailed Word Document icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eReviews how political, economic, social, technological, environmental, and legal forces shape Veeva Systems Inc.’s strategy and growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Customizable Excel Spreadsheet icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eA concise Veeva Systems PESTLE snapshot that quickly highlights external risks, easing strategy reviews and team alignment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Reference-Icon.svg\" alt=\"References icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eReference Sources\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eCites primary industry reports, government datasets, and vendor disclosures to validate Veeva market, pricing, and competitive assumptions for fast, traceable decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eEconomic factors\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSubscription SaaS revenue model\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVeeva’s recurring enterprise contracts keep revenue steadier than one-time software sales; its FY2025 revenue was about $2.75B, and subscriptions drove most of it. Still, renewal rates matter because even small churn hits future billings. When pharma IT budgets tighten, new seat growth and module upsells can slow, so budget cycles shape near-term demand.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma R\u0026amp;D spend levels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePharma R\u0026amp;D budgets keep driving Veeva Systems Inc. demand: when drugmakers spend more on research, they buy more Vault, clinical, regulatory, and quality tools to automate trials and filings. Veeva ended FY2025 with about $2.75 billion in revenue, showing how tied its mix is to industry R\u0026amp;D flow.\u003c\/p\u003e\n\u003cp\u003eIn 2025, large biopharma groups still kept R\u0026amp;D near record highs, so digital process spend stayed firm. If budgets tighten, Veeva can see slower project starts, smaller rollouts, and more delay in new modules.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal currency volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVeeva Systems Inc. reported FY2025 revenue of about $2.75 billion, so even a 1% currency move can swing reported sales by roughly $27.5 million. Because Veeva bills across Europe and Asia Pacific but reports in U.S. dollars, euro and yen weakness can cut translated revenue and squeeze margins. That also shifts customer budgets and deal value on multi-year contracts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eEnterprise cost optimization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eLife sciences firms are pushing for lower SG\u0026amp;A and faster delivery, so software that automates sales, content, compliance, and trial work still wins budget. Veeva Systems Inc. reported FY2025 revenue of about $2.75 billion and operating cash flow near $1.1 billion, which shows buyers kept paying for productivity tools even under cost pressure.\u003c\/p\u003e\n\u003cp\u003eStill, tighter spend control can slow procurement and stretch deal cycles, especially in large pharma. That makes Veeva Systems Inc. strongest where its tools clearly cut manual work and help teams do more with fewer people.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCost cuts favor workflow automation.\u003c\/li\u003e\n\u003cli\u003eFY2025 revenue: about $2.75 billion.\u003c\/li\u003e\n\u003cli\u003eProcurement cycles can take longer.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eBiotech funding cycles\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSmaller biotech buyers are still tied to venture rounds, IPO windows, and capital raises, so Veeva Systems Inc. tends to see faster bookings when money is flowing. In Veeva Systems Inc. fiscal 2025, revenue reached $2.75 billion, showing how recurring demand can hold up even as funding cycles swing. When capital markets weaken, implementation starts and add-on modules often slip.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\u003cp\u003eStrong funding = quicker software buys\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eWeak IPOs = slower new bookings\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eVeeva Systems Inc. FY2025 revenue: $2.75 billion\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVeeva Holds Up as Pharma IT Budgets Slow\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVeeva Systems Inc. is still tied to pharma IT spending, so slower R\u0026amp;D budgets, longer procurement cycles, and weaker biotech funding can delay new deals and module upsells. FY2025 revenue was about $2.75B, and operating cash flow was near $1.1B, showing resilient demand even with cost pressure.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eFY2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$2.75B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOperating cash flow\u003c\/td\u003e\n\u003ctd\u003e~$1.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDemand risk\u003c\/td\u003e\n\u003ctd\u003eR\u0026amp;D and funding cycles\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eVeeva Systems Inc. PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Veeva Systems Inc. PESTLE Analysis you’ll receive after purchase—fully formatted, professionally structured, and ready to use for strategic or investment decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Social-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eSociological factors\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatient-centric engagement demand\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePatients now expect simple digital touchpoints, not just clinician-led steps, so tools like MyVeeva for Patients fit a clear market shift. Veeva Systems Inc. reported about $2.75 billion in FY2025 revenue and serves more than 1,000 customers, showing the scale behind this demand. When sponsors and providers want convenience, transparency, and self-service, Veeva’s digital engagement stack becomes harder to ignore.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRemote HCP communication norms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHealthcare professionals have shifted toward email, portals, and virtual detailing, and Veeva has leaned into that change: FY2025 revenue reached about $2.75 billion, with Commercial Cloud still a core driver. That makes CRM Engage, Approved Email, and closed-loop communication more valuable, since omnichannel contact is now a standard expectation in many markets. In practice, tighter remote workflows help capture engagement data and speed follow-up.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Social-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAgeing population pressure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAgeing populations are lifting demand for medicines, clinical trials, and long-term care; the UN says people aged 65+ will rise from about 10% of the world in 2022 to 16% by 2050. That pushes Veeva Systems Inc. customers to run larger, more complex, and more compliant digital workflows. It also raises the bar on safety, adherence, and patient experience.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eTrust and privacy expectations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTrust and privacy expectations are central to Veeva Systems Inc. because customers in life sciences expect careful handling of patient, physician, and trial data. A single misuse issue can erode brand trust fast in regulated markets, where GDPR fines can reach 4% of global annual turnover. Veeva Systems Inc.'s value depends on secure, controlled, auditable workflows.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePatient, physician, and trial data need strict control\u003c\/li\u003e\n\u003cli\u003eMisuse claims can damage trust fast\u003c\/li\u003e\n\u003cli\u003eAuditable workflows support Veeva Systems Inc.'s value\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eTalent demand in regulated tech\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVeeva Systems Inc. benefits from a tight talent market in regulated tech: buyers need teams that know both software and life sciences rules. That keeps demand high for implementation, validation, and compliance experts, while Veeva’s services and managed support help bridge the gap. Veeva reported about $2.75 billion in FY2025 revenue, showing how valuable that skills-heavy model is.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDual skill sets are scarce.\u003c\/li\u003e\n\u003cli\u003eServices reduce customer hiring pressure.\u003c\/li\u003e\n\u003cli\u003eCompliance work supports sticky revenue.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVeeva’s Growth Tracks the Shift to Smarter, Safer Digital Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVeeva Systems Inc. benefits from a patient base that wants simpler digital care, while life sciences teams expect faster, remote, and self-service contact. FY2025 revenue was about $2.75 billion, and Veeva served more than 1,000 customers, which shows how broad this shift is. Trust, privacy, and audited workflows stay central because patient and trial data are highly sensitive. Ageing populations also support demand for more clinical, safety, and engagement tools.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eFactor\u003c\/th\u003e\n\u003cth\u003eLatest data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2025 revenue\u003c\/td\u003e\n\u003ctd\u003eAbout $2.75 billion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCustomers\u003c\/td\u003e\n\u003ctd\u003eMore than 1,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal age 65+ share\u003c\/td\u003e\n\u003ctd\u003e10% in 2022, 16% by 2050\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Technological-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eTechnological factors\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCloud-native Vault platform\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVeeva Systems Inc.’s Vault is a cloud-native platform, and that matters in regulated work because updates roll out once, not site by site. In FY2025, Veeva reported $2.75 billion in revenue, showing strong demand for its cloud model. Central controls also help keep quality and compliance rules consistent across teams.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAI and analytics adoption\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLife sciences buyers want faster reads on commercial and R\u0026amp;D data, and Veeva Systems Inc. is meeting that with analytics, Data Cloud, and cross-channel reporting. In FY2025, Veeva Systems Inc. reported $2.75 billion in revenue, showing demand for tools that improve forecasting and decisions.\u003c\/p\u003e\n\u003cp\u003eAI-driven use cases are rising in content, clinical trials, and commercial ops, where teams need faster review and cleaner data flow. That shift supports Veeva Systems Inc.'s push to turn fragmented data into usable insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Technological-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInteroperability and APIs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVeeva Systems Inc. depends on open APIs so its cloud apps can link with CRM, clinical systems, data warehouses, and third-party tools without heavy custom work. That matters because Veeva reported about $2.75 billion in FY2025 revenue, and smoother integration helps protect renewals in global IT stacks. Open interfaces also cut deployment friction.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eCybersecurity and identity controls\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eClinical, regulatory, and commercial datasets are prime cyber targets, so Veeva Systems Inc. must keep strong authentication, logging, access control, and encryption in place. IBM put the global average breach cost at $4.88 million in 2024, and regulated-cloud buyers now judge vendors on security as much as features. In this market, weak identity controls can kill a deal.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eUse MFA, least privilege, and audit logs.\u003c\/li\u003e\n\u003cli\u003eEncrypt data in transit and at rest.\u003c\/li\u003e\n\u003cli\u003eSecurity is a buying filter for Veeva Systems Inc.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eDigital validation requirements\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eDigital validation is a core technical need in life sciences, where systems must prove traceability, control changes, and stay audit-ready across clinical, quality, and regulatory work. Veeva Systems Inc. reports over 1,000 customers and 50%+ market share in regulated cloud apps, so its design must support validated use without slowing releases.\u003c\/p\u003e\n\u003cp\u003eThat matters because FDA 21 CFR Part 11 and EU Annex 11 expect secure records, access control, and full audit trails. Veeva’s service model has to help customers keep these controls intact while moving data and workflows across the Vault platform.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eValidation protects audit readiness.\u003c\/li\u003e\n\u003cli\u003eTraceability cuts compliance risk.\u003c\/li\u003e\n\u003cli\u003eControlled change management is essential.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVeeva’s Cloud-Native Vault Scales With AI, Security, and $2.75B Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVeeva Systems Inc.’s cloud-native Vault keeps regulated updates centralized, which helps with validation and audit control across clinical and quality work. In FY2025, Veeva Systems Inc. reported $2.75 billion in revenue, and that scale supports continued spending on AI, analytics, and open APIs.\u003c\/p\u003e\n\u003cp\u003eSecurity is still a top tech filter: IBM pegged the average global breach cost at $4.88 million in 2024, so strong encryption, MFA, and logging matter.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eVeeva Systems Inc. FY2025 revenue\u003c\/td\u003e\n\u003ctd\u003e$2.75 billion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal average breach cost\u003c\/td\u003e\n\u003ctd\u003e$4.88 million\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Legal-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eLegal factors\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGDPR and privacy compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVeeva Systems Inc. handles personal data across Europe and global markets, so GDPR rules on consent, retention, transfers, and breach notices stay central. GDPR fines can reach €20 million or 4% of worldwide annual turnover, whichever is higher, and regulators can add audits and processing limits. Any lapse can hurt customer trust fast, especially in life sciences data flows. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHIPAA-covered health data\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVeeva Systems Inc. serves U.S. healthcare workflows where protected health information can pass through CRM, content, and quality tools, so HIPAA controls matter. In fiscal 2025, Veeva reported $2.75 billion in revenue, and HIPAA expectations shape product design, contracts, and customer onboarding. That means strong admin, technical, and physical safeguards are not optional; they are built into implementation and access controls.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Legal-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e21 CFR Part 11 controls\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003e21 CFR Part 11 is a core legal risk for Veeva Systems Inc. because electronic records and e-signatures sit inside clinical, quality, and regulatory workflows. The rule drives strict audit trails, role-based access, and system validation, so Veeva must prove data integrity and traceability at every step. Any gap can slow customer adoption and trigger compliance findings in regulated life sciences operations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eEU MDR and IVDR pressure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEU MDR and IVDR keep raising the bar on clinical evidence, technical files, and post-market surveillance, so even routine product updates need stronger documentation controls. Veeva Vault Quality and regulatory tools can help life sciences customers track change control, audits, and submissions in one system. For Veeva Systems Inc., Europe’s shifting rules can drive implementation work, but they also add compliance complexity and longer sales cycles.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMDR: tougher device documentation\u003c\/li\u003e\n\u003cli\u003eIVDR: stricter diagnostic evidence\u003c\/li\u003e\n\u003cli\u003eVault tools support compliance workflows\u003c\/li\u003e\n\u003cli\u003eEU change boosts demand and complexity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eAnti-bribery and promotion rules\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVeeva Systems Inc. must design CRM, email, event, and content tools for pharma rules on anti-kickback, transparency, and promotion, because a single bad workflow can trigger fines, audits, and lost contracts. In FY2025, Veeva Systems Inc. reported $2.75 billion in revenue, so compliance failure would hit a large installed base. \u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eControls must block improper speaker fees and gifts.\u003c\/li\u003e\n\u003cli\u003eAudit trails matter for transparency reporting.\u003c\/li\u003e\n\u003cli\u003ePromo content needs approval and version control.\u003c\/li\u003e\n\u003cli\u003eWeak workflows raise legal and customer risk.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVeeva Faces Growing GDPR, HIPAA, and Part 11 Compliance Risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVeeva Systems Inc. faces tight legal pressure from GDPR, HIPAA, and 21 CFR Part 11 because its cloud tools handle regulated life sciences data and electronic records. In fiscal 2025, revenue was $2.75 billion, so any compliance lapse could hit a large customer base and trigger fines, audits, or slower renewals.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eLegal factor\u003c\/th\u003e\n\u003cth\u003eKey risk\u003c\/th\u003e\n\u003cth\u003eFY2025 data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGDPR\u003c\/td\u003e\n\u003ctd\u003ePrivacy, transfers, breach rules\u003c\/td\u003e\n\u003ctd\u003e€20 million or 4% fine cap\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHIPAA\u003c\/td\u003e\n\u003ctd\u003ePHI safeguards in U.S. workflows\u003c\/td\u003e\n\u003ctd\u003e$2.75 billion revenue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e21 CFR Part 11\u003c\/td\u003e\n\u003ctd\u003eAudit trails, e-signatures, validation\u003c\/td\u003e\n\u003ctd\u003eCore to clinical and quality tools\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Enviromental-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eEnvironmental factors\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePaperless workflow shift\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVeeva Systems Inc. replaces paper-heavy review and approval steps with digital workflows, cutting printing, courier use, and physical storage. In fiscal 2025, Veeva reported about $2.75 billion in revenue, showing the scale at which this paperless model can spread across life sciences customers. That helps customers lower waste and supports their ESG targets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eData center energy use\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCloud software like Veeva Systems Inc. depends on data centers, and those facilities already use about 1% to 1.5% of global electricity. Better hosting, cleaner grids, and tighter workload management can cut emissions without hurting service levels. Buyers now ask vendors for carbon data and low-carbon cloud plans, so energy use is part of software procurement, not just IT.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Enviromental-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eESG reporting demand\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eESG reporting demand is rising as large pharma faces tougher disclosure rules, including the EU CSRD, which expands reporting to about 50,000 companies. That pushes buyers to favor vendors with auditable controls and clear ESG policies. For Veeva Systems Inc, this can matter in procurement, since pharma teams want suppliers that support traceable, compliant processes and responsible operations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eTravel reduction through digital engagement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVeeva Systems Inc.’s virtual meetings, approved email, and remote training cut business travel, which lowers fuel use and scope 3 emissions tied to sales and enablement. In fiscal 2025, Veeva posted $2.75 billion in revenue, so even small cuts across a large customer-facing footprint can matter. Its cloud tools also let life sciences teams engage customers with less travel.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLess travel, lower emissions\u003c\/li\u003e\n\u003cli\u003eDigital sales and training scale better\u003c\/li\u003e\n\u003cli\u003eSupports cleaner commercial ops\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eClimate resilience in global operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eExtreme weather is a real operating risk: the U.S. had 27 billion-dollar disasters in 2024, with losses of $182.7 billion, showing how offices, customer sites, and support teams can be hit at once.\u003c\/p\u003e\n\u003cp\u003eFor Veeva Systems Inc., cloud delivery helps keep service running during regional disruption, but only if disaster recovery, backup, and failover are tested and fast.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eWeather can stop local work.\u003c\/li\u003e\n\u003cli\u003eCloud lifts continuity.\u003c\/li\u003e\n\u003cli\u003eRegulated clients need resilience.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVeeva’s Digital Model Cuts Emissions at Scale\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVeeva Systems Inc. benefits from paperless workflows and remote work tools that cut printing, shipping, travel, and related emissions. In fiscal 2025, revenue was about $2.75 billion, so these efficiency gains scale across a large life sciences customer base. Data center power use and cleaner cloud hosting also matter, since buyers now ask vendors for carbon data.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eFactor\u003c\/th\u003e\n\u003cth\u003eLatest data\u003c\/th\u003e\n\u003cth\u003eWhy it matters\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFiscal 2025 revenue\u003c\/td\u003e\n\u003ctd\u003e$2.75 billion\u003c\/td\u003e\n\u003ctd\u003eScale for digital emissions cuts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal electricity\u003c\/td\u003e\n\u003ctd\u003e1% to 1.5%\u003c\/td\u003e\n\u003ctd\u003eData center power pressure\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eU.S. billion-dollar disasters\u003c\/td\u003e\n\u003ctd\u003e27 in 2024\u003c\/td\u003e\n\u003ctd\u003eResilience risk for operations\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"DCF Analyst","offers":[{"title":"Default Title","offer_id":57191779500297,"sku":"veev-pestle-analysis","price":5.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0942\/8045\/0313\/files\/veev-pestle-analysis.webp?v=1783677643","url":"https:\/\/dcfanalyst.com\/products\/veev-pestle-analysis","provider":"DCF Analyst","version":"1.0","type":"link"}